ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "osteoporosis"

  • Abstract Number: 0133 • ACR Convergence 2020

    Pharmacist-Driven Clinic Development for Patients with Incidental Vertebral or Hip Fractures

    Julie Ferm1, Lanh Dang1 and Gurjit Kaeley2, 1UF Health Jacksonville, Jacksonville, FL, 2University of Florida College of Medicine - Jacksonville, Jacksonville, FL

    Background/Purpose: Non-traumatic vertebral and hip fractures are detrimental complications of osteoporosis and those with a previous fracture have double the risk of subsequent fractures. The…
  • Abstract Number: 1973 • ACR Convergence 2020

    Treatment Sequences with Romosozumab Before or After Antiresorptive Medication

    Felicia Cosman1, David Kendler2, Bente Langdahl3, Benjamin Z Leder4, E Michael Lewiecki5, Akimitsu Miyauchi6, Maria Rojeski7, Michele McDermott7, Mary Oates7, Cassandra E Milmont8, Cesar Libanati9 and Serge Ferrari10, 1Columbia University, New York, NY, 2University of British Columbia, Vancouver, BC, Canada, 3Aarhus University Hospital, Aarhus, Denmark, 4Mass General Hospital, Harvard Medical School, Boston, MA, Boston, MA, 5New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, 6Miyauchi Medical Center, Osaka, Japan, 7Amgen Inc., Thousand Oaks, CA, 8Amgen Inc., Thousand Oaks, 9UCB Pharma, Brussels, Belgium, 10Geneva University Hospital, Geneva, Switzerland

    Background/Purpose: Prior studies of anabolic/antiresorptive treatment sequences indicate that using teriparatide first followed by an antiresorptive results in greater bone mineral density (BMD) gains, particularly…
  • Abstract Number: 0115 • ACR Convergence 2020

    Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project

    Khiem Vu1, Chima Ohadugha1, Kevin Dao1, Rabih Nayfe2 and Andrew Mangano1, 1Grand Strand Medical Center, Myrtle Beach, SC, 2Carolina Health Specialists - Rheumatology, Myrtle Beach, SC

    Background/Purpose: There are known indications for osteoporosis screening in women. However, osteoporosis also occurs in men and fragility fractures are linked to increased morbidity and…
  • Abstract Number: 0188 • ACR Convergence 2020

    The Risk of Fractures in a Community-based Cohort of Patients with Rheumatoid Arthritis Compared with the Background Population

    Lisa Theander1, Jan Åke Nilsson2, Minna Willim3, Lennart T.H. Jacobsson4 and Carl Turesson5, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Sweden, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University. Department of Rheumatology, Skåne University Hospital, Malmö and Lund, Sweden, Malmö, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund, Lund University. Department of Rheumatology, Skåne University Hospital, Malmö and Lund, Sweden, Malmö, Sweden, 4Rheumatology, Department of Clinical Sciences, Malmö, Lund University. Department of Rheumatology and inflammation research, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden., Gothenburg, Sweden, 5Rheumatology, Department of Clinical Sciences Malmö, Lund University, Department of Rheumatology, Skåne University Hospital, Malmö, Sweden., Malmö, Sweden

    Background/Purpose: Rheumatoid Arthritis (RA) has been associated with increased risk of osteoporosis and fractures. We have recently presented results on DXA measurements over 10 years…
  • Abstract Number: 1974 • ACR Convergence 2020

    Validation of a Deep Learning Based Algorithm to Diagnose Vertebral Compression Fractures

    John Page1, Franklin Moser2, Marcel Maya3, Ravi Prasad3 and Barry Pressman2, 1Amgen, Inc, Thousand Oaks, CA, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Cedars-Sinai Medical Center, Los Angeles

    Background/Purpose: Vertebral Compression Fractures are common in patients above age 50, but are often undiagnosed.  Patients with one VCF are at higher risk of other…
  • Abstract Number: 0117 • ACR Convergence 2020

    Development of an In Vitro Trabecular Human Bone Model to Recapitulate Features of Glucocorticoid-induced Osteoporosis

    Annemarie Lang1, Karoline Diesing1, Alexandra Damerau1, Moritz Pfeiffenberger1, Timo Gaber1 and Frank Buttgereit2, 1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany, 2Charité University Medicine, Berlin, Germany

    Background/Purpose: The bone matrix consists of inorganic and organic components and a variety of specialized cells such as osteoblasts, osteocytes and osteoclasts. The bone-forming osteoblasts…
  • Abstract Number: 0394 • ACR Convergence 2020

    Prevalence of a Diagnosis of Osteopenia/Osteoporosis Amongst Patients with Systemic Sclerosis and Identification of Associated Clinical Factors

    Guanying Wang1, Diane Mar2, Joy Wu3, Julia Simard4, Rita Popat1 and Lorinda Chung5, 1Department of Epidemiology & Population Health, Stanford University School of Medicine, Palo Alto, CA, 2Stanford Department of Immunology/Rheumatology, Palo Alto, CA, 3Department of Medicine, Division of Endocrinology, Stanford University School of Medicine, Palo Alto, CA, 4Stanford Medicine, Stanford, CA, 5Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA

    Background/Purpose: This study aims to determine the prevalence of a diagnosis of osteopenia/osteoporosis (OP) in systemic sclerosis (SSc) patients and to identify the clinical and…
  • Abstract Number: 1975 • ACR Convergence 2020

    Predicting Bone Mineral Density of Lumbar Vertebrae by Assessing Plain Film with Deep Learning

    Chen-I Hsieh1, Chang-Fu Kuo1, Shun Miao2, Kang Zheng2 and Le Lu2, 1Chang Gung Memorial Hospital, Taoyuan, Taiwan (Republic of China), 2PAII labs, Bethesda, MD

    Background/Purpose: Osteoporosis is a silent disease characterized by a decrease in bone mineral density (BMD), causing bone fragility and increased risk of fracture. The most…
  • Abstract Number: 0090 • ACR Convergence 2020

    110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition

    Michael Lovy1 and Andrew Dulalia1, 1Desert Oasis Healthcare, Palm Springs, CA

    Background/Purpose: Monoclonal gammopathy of undetermined significance (MGUS) has been associated with osteoporosis, neuropathy, pernicious anemia, and low vitamin B12, and may precede multiple myeloma and…
  • Abstract Number: 0118 • ACR Convergence 2020

    Indicators of Effectiveness After 6 Years of Follow-up in a Fracture Liaison Service

    Antonio Naranjo Hernandez1, Amparo Molina2, Cristina Sepúlveda2, Francisco Rubiño3, Adrian Quevedo3 and Soledad Ojeda3, 1Hospital Universitario Dr Negrin, Las Palmas, Canarias, Spain, 2Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas, Spain, 3Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas

    Background/Purpose: Data on the effectiveness of FLS in the medium and long term are needed. The objetive of this study was to analyze the indicators of…
  • Abstract Number: 0533 • ACR Convergence 2020

    Characterization of Older Male Patients with a Fragility Fracture

    Setareh A Williams1, Shanette G Daigle2, Richard Weiss1, Yamei Wang1, Tarun Arora2 and Jeffrey R Curtis3, 1Radius Health, Inc., Waltham, MA, Waltham, MA, 2University of Alabama at Birmingham, Birmingham, AL, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Osteoporosis is associated with significant burden in terms of adverse patient outcomes, mortality, and cost; and is particularly common in the older Medicare population.…
  • Abstract Number: 1976 • ACR Convergence 2020

    High Disease Activity Is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis

    Katherine Wysham1, Ted Mikuls2, Bryant England2, Dolores Shoback3, Patricia Katz4, Jose Garcia1, Brian Sauer5, Beth Wallace6, John Richards7, Paul Monach8, Grant Cannon9 and Joshua Baker10, 1VA Puget Sound/University of Washington, Seattle, WA, 2University of Nebraska Medical Center, Omaha, NE, 3San Francisco VA/University of California, San Francisco, San Francisco, CA, 4University of California, San Francisco, Novato, CA, 5University of Utah, Omaha, NE, 6Michigan Medicine, VA Ann Arbor Healthcare System Center for Clinical Management Research, Ann Arbor, MI, 7Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 8Brigham and Women's, Boston, 9Salt Lake City VA Medical Center and University of Utah, Salt Lake City, 10University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Rheumatoid arthritis (RA) is a risk factor for osteoporosis and fractures yet the disease specific contributions to osteoporotic fractures (OFX) are not well understood.…
  • Abstract Number: 0101 • ACR Convergence 2020

    Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass

    Michael R McClung1, Michael A Bolognese2, Jacques P Brown3, Jean-Yves Reginster4, Bente Langdahl5, Norma Ruiz-Santiago6, Yifei Shi6, Maria Rojeski6, Jen Timoshanko7, Cesar Libanati7, Helina Kassahun6 and Mary Oates6, 1Oregon Osteoporosis Center, Portland, OR, 2Bethesda Health Research Center, Bethesda, MD, 3Laval University and CHU de Québec (CHUL) Research Centre, Québec City, Canada, 4University of Liège, Liège, Belgium, 5Aarhus University Hospital, Aarhus, Denmark, 6Amgen Inc., Thousand Oaks, CA, 7UCB Pharma, Brussels, Belgium

    Background/Purpose: Romosozumab, an anti-sclerostin antibody that increases bone formation while decreasing bone resorption, reduces fracture risk within 12 months. Here we evaluate the effects of…
  • Abstract Number: 0119 • ACR Convergence 2020

    Fracture Liaison Service at an Academic Center with an Open Health System: 30-month Outcomes

    Donna Jose1, Micah Yu2, Karina Torralba3, Christina Downey4, Justin Dunn5 and Vinicius Cabido5, 1Loma Linda University Medical Center, Ontario, CA, 2Loma Linda University Medical Center, Loma Linda, CA, 3Loma Linda University School of Medicine, Redlands, CA, 4Loma Linda University Medical Center, Redlands, CA, 5Loma Linda University Medical Center, Loma Linda

    Background/Purpose: Osteoporosis causes significant morbidity, mortality and healthcare burden. There continues to be a care gap in osteoporosis recognition, treatment and prevention. Several healthcare systems…
  • Abstract Number: 0544 • ACR Convergence 2020

    Risk Factors for Lumbar Vertebral Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip

    Marwan Bukhari1 and Mrinalini Dey2, 1Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom, 2Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom

    Background/Purpose: The most common site of osteoporotic fragility fractures is the thoracic spine. However, bone mineral density (BMD) measurements at the hip are used to…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology